Compound library / Hair Loss

Finasteride (Propecia)

Oral 5-alpha-reductase type II inhibitor that lowers DHT, FDA-approved for male pattern hair loss.

CategoryHair Loss
Regulatory standingApproved medicine
Typical routeOral
Half-life~5-6 hours
Common dose range1 mg/day (hair loss dose; 5 mg/day is the BPH dose)
Typical cycle lengthOngoing — benefits reverse within months of stopping

BioHack Track models Finasteride (Propecia) at a half-life of 5.5 hours, so every dose you log is decayed against that curve and the app shows estimated active levels — not just what you typed.

Approved medicine

An FDA-approved product containing this compound exists, and its label is linked under Primary sources below. That label is the authority on dosing; the range on this page describes what people commonly track, including off-label use, and does not replace it.

Reconstitution

Oral tablet; no reconstitution needed. Topical/oral compounded versions also exist.

Storage

Store at room temperature.

Cautions

Prescription medication. Small risk of sexual side effects (some persisting after discontinuation in rare reports — "post-finasteride syndrome" is debated); not for use by women who are or may become pregnant.

Track Finasteride (Propecia) in BioHack Track. Half-life, dose range and route come pre-filled from this library — log a dose and the app counts your vial down, models what is in your system, and puts it on the same chart as your labs and body composition.

Others in Hair Loss

Look up the research

These open a search of each database for Finasteride (Propecia) — they are not citations, and nothing here is evidence for any particular dose. The same links are in the app.

Work it out

Where these figures come from

The half-life, route and dose range on this page are compiled from published pharmacokinetic literature, manufacturer and product monographs where one exists, and the ranges commonly reported in clinical and research use. They are kept as a range rather than a single figure because that is what the sources actually support — a half-life varies with route, formulation and the person.

These are not citations, and this page is not a review of the evidence. Where a number matters to you, follow the database links above and read the source. We say so plainly rather than dressing a compiled reference up as one.

Nothing on this page has been reviewed by a named clinician. It is a reference for people already tracking a protocol, not a recommendation to start one.

Published by Creative Images LLC · Last updated · Corrections: support